Republicans contend with lack of drug policy action, despite controlling Congress
Drug costs are too high, lawmakers agreed at a Senate committee hearing this week. But industry pushback and delays have stalled reform of a system experts say is rigged.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.